Clinical Impact of Malaria Rapid Diagnostic Testing at a US Children's Hospital [0.03%]
疟疾快速诊断在美国儿童医院的临床影响
Leslie A Enane,Kaede V Sullivan,Evangelos Spyridakis et al.
Leslie A Enane et al.
Background: Children who develop malaria after returning to a setting in which the disease is not endemic are at high risk for critical delays in diagnosis and initiation of antimalarial therapy. We assessed the clinical ...
Manuel E Penton,Caitlin Otto,Margaret R Hammerschlag
Manuel E Penton
Background: Outsourcing of microbiology laboratory services is a growing trend in US medical centers. Data on the actual impact of outsourcing on patient care, safety, and medical education, including costs, are limited. ...
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study [0.03%]
多替拉韦治疗经治青少年人类免疫缺陷病毒感染的长期安全性和疗效：IMPACT研究P1093结果
Rolando M Viani,Theodore Ruel,Carmelita Alvero et al.
Rolando M Viani et al.
Background: P1093 is an ongoing phase I/II multicenter open-label study of dolutegravir plus an optimized background regimen in age-defined pediatric cohorts; here we report the long-term safety and virologic efficacy out...
Effect of Hepatitis C Virus Coinfection on the Progression of Vertically Acquired Human Immunodeficiency Virus Infection During Childhood and Adolescence [0.03%]
丙型肝炎病毒感染对儿童和青少年先天性人类免疫缺陷病毒病程的影响
Carolina Fernández-McPhee,Talía Sainz,María José Mellado et al.
Carolina Fernández-McPhee et al.
Data for a total of 57 patients vertically coinfected with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) and 365 HIV-monoinfected patients were compared until their transition to adult care. No differences regarding the dynamic...
Invasive Group A Streptococcus Infection in Children in Southern Israel Before and After the Introduction of Varicella Vaccine [0.03%]
以色列Varicella疫苗引入前后南方儿童侵袭性A族链球菌感染状况分析
Ori Hasin,Guy Hazan,Assaf Rokney et al.
Ori Hasin et al.
The annual rates of group A Streptococcus bacteremia per 100 000 children in southern Israel declined after introduction of the varicella vaccine to the national immunization program, from 2.43 (95% confidence interval, 1.73-3.13) in 1995-2...
Subacute Aerococcus urinae Infective Endocarditis With Mycotic Aneurysms in a Pediatric Patient: Case Report and Literature Review [0.03%]
儿童患者患亚急性尿路链球菌感染性心内膜炎并真菌动脉瘤的病例报告和文献回顾
Natalie Sous,Julia A Piwoz,Aryeh Z Baer et al.
Natalie Sous et al.
Aerococcus urinae has been found to cause urinary tract infection in elderly patients and has been reported as a rare cause of infective endocarditis associated with significant morbidity and death in adults. However, information regarding ...
Janet R Gilsdorf
Janet R Gilsdorf
With the eradication of poliomyelitis in the United States, the appearance of acute flaccid myelitis outbreaks has raised questions regarding their causation. Review of the epidemiology, clinical aspects, and laboratory findings of bygone c...
Clinical Characteristics and Outcome of Children Hospitalized With Scrub Typhus in an Area of Endemicity [0.03%]
恙虫病流行区住院儿童的临床特征及转归
Tri Wangrangsimakul,Rachel C Greer,Chulapong Chanta et al.
Tri Wangrangsimakul et al.
Background: Scrub typhus, caused by Orientia tsutsugamushi, is a major cause of acute febrile illness in children in the rural tropics. Methods: ...
A Pilot Study to Reduce Central Line-Associated Bloodstream Infections in Children From Extremely Low-Income Settings With Intestinal Failure-Meeting the Challenge [0.03%]
一项针对极端低收入环境下肠功能衰竭儿童减少中心静脉导管相关血流感染的试点研究——迎接挑战
Inbal Fuchs,Dov Rosenbaum,Ilana Klein et al.
Inbal Fuchs et al.
Background: Central line-associated bloodstream infections (CLABSIs) are major sources of morbidity, death, and healthcare costs in patients who receive home parenteral nutrition (HPN). The majority of HPN-dependent child...
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study [0.03%]
一种麻疹-腮腺炎-风疹联合减毒活疫苗初次免疫12至15月龄儿童的安全性及免疫原性：III期、随机、非劣效性、批次间一致性研究
Nicola P Klein,Remon Abu-Elyazeed,Michael Povey et al.
Nicola P Klein et al.
Background: MMR II (M-M-R II [Merck & Co, Inc.]) is currently the only measles, mumps, and rubella (MMR) vaccine licensed in the United States. A second MMR vaccine would mitigate the potential risk of vaccine supply shor...